...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: NASH is a $35 Billion US/year market

ALP is/ was an approvable surrogate endpoint for Ocalivia / Intercept

I believe RVX is measuring ALP levels in the CKD cohort of BetonMace ?

If one believes Tundup 6/21 post we are  Aces.

Do I have this wrong ?

Thanks as always !

 

Share
New Message
Please login to post a reply